Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 May 3;12(5):946-57.
doi: 10.3390/12050946.

Cancer preventive mechanisms of the green tea polyphenol (-)-epigallocatechin-3-gallate

Lei Chen  1 , Hong-Yu Zhang
Affiliations
Review

Cancer preventive mechanisms of the green tea polyphenol (-)-epigallocatechin-3-gallate

Lei Chen et al. Molecules. .

Abstract

Accumulating evidence indicates that consumption of tea, especially green tea, is good for preventing cancer. To elucidate the cancer preventive mechanisms of green tea, much effort has been devoted to investigating the anticancer effects of (-)-epigallocatechin-3-gallate (EGCG), the major component of green tea. It has been revealed that EGCG restrained carcinogenesis in a variety of tissues through inhibition of mitogen-activated protein kinases (MAPK), growth factor-related cell signaling, activation of activator protein 1 (AP-1) and nuclear factor-B (NF-kappaB), topoisomerase I, matrix metalloproteinases and other potential targets. Therefore, EGCG is a multipotent anticancer agent, which not only provides solid evidence to support the anticancer potential of green tea, but also offers new clues for discovering multiple-targeted anticancer drugs.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Main catechin components of green tea polyphenols.
Figure 2
Figure 2
Intracellular signaling pathways and its modulation by EGCG.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Fujiki H., Suganuma M., Imai K., Nakachi K. Green tea: Cancer preventive beverage and/or drug. Cancer Lett. 2002;188:9–13. doi: 10.1016/S0304-3835(02)00379-8. - DOI - PubMed
    1. Imai K., Suga K., Nakachi K. Cancer-preventive effects of drinking green tea among a Japanese population. Prev. Med. 1997;26:769–775. doi: 10.1006/pmed.1997.0242. - DOI - PubMed
    1. Inoue M., Tajima K., Hirose K., Hamajima N., Takezake T., Kuroishi T., Tominaga S. Tea and coffee consumption and risk of digestive tract cancers: data from a comparative case-referent study in Japan. Cancer Causes Control. 1998;9:209–216. - PubMed
    1. Ji B. T., Chow W. H., Hsing A. W., McLaughlin J. K., Dai Q., Gao Y. T., Blot W. J., Fraumeni J. F. Green tea consumption and the risk of pancreatic and colorectal cancers. Int. J. Cancer. 1999;70:255–258. - PubMed
    1. Nakachi K., Suemasu K., Suga T., Takeo K., Imai K., Higashi Y. Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn. J. Cancer Res. 1998;89:254–261. doi: 10.1111/j.1349-7006.1998.tb00556.x. - DOI - PMC - PubMed

Publication types

MeSH terms

-